6 results
· To determine therapeutic efficacy of Tracleer in patients with active Behcet disease. Furthermore:· To study cytokine and immunological patterns and ET-1levels in those patients.
The objective of this trial is to demonstrate that bosentan delays disease worsening or death in patients with IPF.
To assess long-term safety and tolerability of bosentan in patients with IPF.
The objective of this trial is to investigate the feasibility and safety of helium ventilation post cardiac arrest.
The primary objective is to investigate the feasibility and the safety of heliox administration, a gaseous mixture of 79% helium en 21% oxygen, for 8 hours in acute ischemic stroke.
To investigate whether the inhalation of helium during rpimary PCI can reduces the size of myocardial infarction.